Skip to content

The effects of Cognitive Behavioral counseling on anxiety and worry of pregnant women around the screening of fetal chromosomal abnormality

The effects of Cognitive Behavioral counseling on anxiety and worry of pregnant women around the screening of fetal chromosomal abnormality

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20160608028352N8
Enrollment
52
Registered
2020-08-29
Start date
2020-09-05
Completion date
Unknown
Last updated
2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Worry. Condition 2: Anxiety. Unhappiness Anxiety disorder, unspecified

Interventions

Intervention 1: Intervention group: The members of the intervention group will be 26 people who will participate in the telephone counseling individually. Cognitive-Behavioral telephone counseling wit

Sponsors

Zanjan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Having intermediate results in screening in the first trimester of pregnancy Willingness to participate and collaborate in research Have a minimum literacy Gestational age less than 14 weeks of pregnancy Not having any physical illness Pregnant woman does not have known mental illness and not taking drugs that affect the psyche. No complications such as miscarriage, moles, bleeding, etc.

Exclusion criteria

Exclusion criteria: Reluctance to participating in research and absence for more than two sessions Pregnant woman with known mental illnesses and the use of psychotropic drugs that are self-reported. Problems during pregnancy (miscarriage, moles, etc.) that cause double anxiety.

Design outcomes

Primary

MeasureTime frame
Worry of pregnant women around the screening of fetal chromosomal abnormality. Timepoint: At baseline, immediately after the intervention and 20-22 week. Method of measurement: Cambridge Worry Questionnaire.;Anxiety of pregnant women around the screening of fetal chromosomal abnormality. Timepoint: At baseline, immediately after the intervention and 20-22 week. Method of measurement: Pregnancy Related Anxiety Questionnaire (Van den Berg).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactEsmat Vaezi

Zanjan University of Medical Sciences

vaezi.esmat@gmail.com+98 24 3315 6344

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 8, 2026